Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Molecular Cell|January 16, 2007
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgammaSerena Ghisletti, Wendy Huang, Sumito Ogawa, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3Kareem A Galal, Andreas Krämer, Benjamin G Strickland, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2024
Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3Kareem A Galal, Andreas Krämer, Benjamin G Strickland, et al.
The Journal of Investigative Dermatology|June 12, 2004
The effect of LXR activators on AP-1 proteins in keratinocytesMatthias Schmuth, Peter M Elias, Karen Hanley, et al.
Cellular Signalling|January 27, 2007
Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytesAndrew D Burdick, Moses T Bility, Elizabeth E Girroir, et al.
Journal of Medicinal Chemistry|August 9, 2002
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activityRoberto Pellicciari, Stefano Fiorucci, Emidio Camaioni, et al.
Drug Discovery Today|January 13, 2024
Illuminating function of the understudied druggable kinomeShawn M Gomez, Alison D Axtman, Timothy M Willson, et al.
The Journal of Biological Chemistry|February 20, 2003
Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanismsRajnish A Gupta, Pasha Sarraf, Elisabetta Mueller, et al.
Pageof 16